Search Results

Filter
  • 1-9 of  9 results for ""Thromboembolism drug therapy""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

New antithrombotic agents-insights from clinical trials

  • Source: Nature Reviews Cardiology. September, 2010, Vol. 7 Issue 9, p498, 12 p.

Record details

×
Academic Journal

Xarelto (rivaroxaban)/Bayer Healthcare (Leverkusen, Germany).

  • Source: Nature Biotechnology. 2008, Vol. 26, Issue 9, pages. 1

Record details

×
Academic Journal

The advent of the novel oral anticoagulants

  • Source: Nature Reviews Cardiology. February 1, 2014, Vol. 11 Issue 2

Record details

×
Academic Journal

Apixaban indications set to AMPLIFY?

  • Source: Nature Reviews Cardiology. September 1, 2013, Vol. 10 Issue 9

Record details

×
Academic Journal

Venous thromboembolism: Risk of recurrence lower with rivaroxaban than aspirin

  • Source: Nature Reviews Cardiology. May, 2017, Vol. 14 Issue 5, p254, 1 p.

Record details

×
Academic Journal

Venous thromboembolism: Thromboprophylaxis with statins

  • Source: Nature Reviews Cardiology. March, 2017, Vol. 14 Issue 3, p130, 1 p.

Record details

×
Academic Journal

Aspirin ASPIRESs to reduce vascular events after VTE

  • Source: Nature Reviews Cardiology. January 1, 2013, Vol. 10 Issue 1, p4a, p1 p.

Record details

×
Academic Journal

Efficacy and safety of daily aspirin

  • Source: Nature Reviews Cardiology. August 1, 2012, Vol. 9 Issue 8, p433, 1 p.

Record details

×
Academic Journal

Xarelto (rivaroxaban)/Bayer Healthcare (Leverkusen, Germany).

  • Source: Nature Biotechnology. September, 2008, Vol. 26 Issue 9, p959, 1 p.

Record details

×
  • 1-9 of  9 results for ""Thromboembolism drug therapy""